- Anxiety is a group of disorders (panic, social, GAD, phobias), affecting 2.5–7% of people — united by exhausting fear and insecurity.
- Its root is the balance of two neurotransmitters: glutamate (excites) vs GABA (calms); chronic anxiety is glutamate dominating GABA.
- Lifestyle first: cut sugar/refined carbs and stimulants, improve sleep; a ketogenic diet is studied for raising GABA.
- Two natural compounds are studied: vitexin (GABA-A modulator, no dependence) and Hericium erinaceus / Lion's Mane (neuroregeneration, NGF).
What is anxiety
If you are looking for the answer to this question, you have probably already met the shadow of anxiety personally. Although the state is not hard to define, it is far more important to understand its origin. Once we grasp what drives anxiety, we can find natural ways to restore inner calm — that sense of ease many of us remember from childhood, when the world did not yet seem so complicated. Our neurological balance often shifts very slowly. It is a process lasting years, so the changes are hard to notice. Most often we only reflect on it when sharp panic attacks strike, or when everyday life becomes wrapped in constant unease.
The variety of anxiety disorders
It is important to understand that anxiety is not one single state — it is a whole group of different disorders. It includes panic attacks, social anxiety, separation anxiety, phobias and, perhaps the most common, generalized anxiety disorder. Although the diagnoses differ, they share a common denominator: an exhausting feeling of fear and insecurity. Anxiety affects between 2.5% and 7% of people, varying by country.2
Why does anxiety arise?

Proper brain function depends on the balance of two neurotransmitters (information carriers). This system regulates itself through two main forces — imagine a scale always seeking balance.8 The two key neurotransmitters are glutamate and GABA, which act in opposition: glutamate excites,9 while GABA inhibits.10 This creates our mental equilibrium. When glutamate dominates over GABA, the result is the over-activated, restless state we experience as anxiety.
What raises anxiety (glutamate) in your brain

To manage anxiety, it is not enough to add new habits — first you need to remove what constantly stimulates your nervous system. The main goal: balance glutamate (the stimulating neurotransmitter) and GABA (the calming one). What to give up or strongly limit: Sugar and fast carbohydrates — sweets, baked goods, sugary drinks and even an excess of sweet fruit cause sharp insulin spikes that directly affect mood swings.14 Excess stimulants, poor sleep and chronic stress also keep glutamate elevated. The tip: get vitamins and minerals far more effectively from dark leafy greens.
How to restore calm: activating GABA
If glutamate is the brain's "accelerator," then GABA (gamma-aminobutyric acid) is its "brakes." To overcome anxiety, we need to activate these brakes — through lifestyle changes and nature-made substances. A ketogenic diet helps fight anxiety and increases GABA,53 so for those following this low-carbohydrate plan it not only helps manage anxiety but also improves memory and cognitive function. More and more specialists recommend dietary correction as the first step before chemical treatment.54
Natural compounds for anxiety
If lifestyle changes are not enough, nature offers two powerful active compounds that can rival medications in effectiveness, without their side effects. There is sufficient research to form a picture of their impressive effect on the brain, so using both together is suggested for those who want to balance brain activity and live calmly amid the enormous information flow of everyday life. These are the flavonoid vitexin and the medicinal mushroom Hericium erinaceus (Lion's Mane).
Vitexin — nature's pulse of calm

From mung beans to buckwheat, vitexin is an antioxidant found in many plants, used as a medicine across continents since ancient times.64 This flavonoid, placed under the scientists' magnifying glass, genuinely surprised researchers with its very broad pharmacological effect.65 Its antioxidant and anti-inflammatory effects are studied, along with neuroprotective, anti-spasm and other properties.66 Scientifically, vitexin is classified as an apigenin flavone glycoside, found in bamboo leaves, passionflower, buckwheat, lavender, mung beans and many more. But eating these foods is not enough to obtain a meaningful amount — strong, specific extracts are needed. Vitexin is studied for acting through the GABA-A receptor pathway in a way comparable to benzodiazepines, but as a modulator rather than a suppressor — which is why it is studied for reducing anxiety without sedation or dependence risk.
Hericium erinaceus (Lion's Mane) — the brain regenerator

H. erinaceus is a medicinal mushroom of especially rare effect, titled the "brain mushroom." Its extract is studied as particularly suited to feelings of anxiety. Neuroregeneration: it is studied for stimulating nerve growth factor (NGF) — in human neuron samples, this mushroom's extract effectively increased neurite outgrowth by 60.6%.86 Research also examines its role in supporting mood and cognitive function. The right extract type, amount and strength matter for effect.
Vitexin is studied for acting through the GABA-A pathway like benzodiazepines but as a modulator, without dependence risk - examined across 80+ clinical studies.
Vitexin 90 by Zenius Labs™ →Anxiety is a natural brain response to threat, regulated by the balance of GABA and glutamate. The problem arises when this system is chronically activated without a real threat. Modern factors — stress, poor sleep, an abundance of refined carbohydrates — continually raise glutamate and lower GABA activity, creating a state of chronic anxiety.
Some plant compounds are studied clinically. Vitexin (from Passiflora incarnata) is studied for acting through GABA-A receptors in a way comparable to benzodiazepines, but without dependence risk. This has been examined across patient groups in more than 80 clinical studies. Always discuss any approach with a healthcare professional.
Prescription sedatives (benzodiazepines) directly suppress the central nervous system and can cause dependence, memory problems and slowed movement. Vitexin 90 by Zenius Labs™ is studied for acting through the same GABA-A receptor pathway but as a modulator rather than a suppressant — studied for reducing anxiety without sedation or dependence. This is informational, not medical advice.
Mild situational anxiety can. But chronic anxiety linked to neurochemical changes usually does not lessen without intervention — and may strengthen over time. It is important to address the cause early (sleep, diet, physical activity, GABA support) rather than wait for symptoms to worsen. Seek professional support where appropriate.
No, but they often go together. Anxiety is an excess of activation and fear; depression is emotional and energetic exhaustion. Both are associated with GABA/serotonin imbalance, which is why some interventions (such as Passiflora incarnata extract) are studied for effects on both.
Chronic anxiety can harm over time: raising cortisol, weakening the immune system and increasing cardiovascular risk. Short-term anxiety is normal and even useful. The problem is when it becomes a background mode of life — so it is important not to leave it unaddressed.
- Moreno-Agostino D et al. Characterising patterns of health behaviours in middle-aged and older adults. BMC Public Health. 2020. biomedcentral.com
- Missing: https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders
- Missing: https://presse.inserm.fr/en/benzodiazepine-use-and-dementia-in-the-over-65s/47631/
- Missing: https://www.researchgate.net/publication/396450394_The_Use_of_Benzodiazepines_in_the_Elderly_Population_Epidemiology_Risks_and_Withdrawal_Management
- Miczke A et al. GABA and anxiety: IntechOpen chapter. IntechOpen. intechopen.com
- Gibson GR et al. Dietary prebiotics: current status and new definition. J Nutr. 2010. oup.com
- Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatric disease and treatment. 2015. PubMed Central
- Nutrients and neurotransmitters: IntechOpen chapter. IntechOpen. intechopen.com
- American Addiction Centers. Long-term effects of Xanax use. AmericanAddictionCenters.org. americanaddictioncenters.org
- MedlinePlus. Alprazolam (Xanax) drug information. MedlinePlus (NIH). medlineplus.gov
- Wang C et al. Glucose inhibits GABA release by pancreatic beta-cells through an increase in GABA shunt activity. Am J Physiol Endocrinol Metab. 2006. PubMed
- Levin BE et al. Regulation of energy homeostasis by peripheral signals. Am J Physiol Regul Integr Comp Physiol. 2017. physiology.org
- Kose J et al. A Comparison of Sugar Intake between Individuals with High and Low Trait Anxiety: Results from the NutriNet-Santé Study. Nutrients. 2021. PubMed
- Alasmari F. Caffeine induces neurobehavioral effects through modulating neurotransmitters. Saudi Pharm J. 2020. PubMed
- John J et al. Caffeine promotes glutamate and histamine release in the posterior hypothalamus. American journal of physiology. Regulatory, integrative and comparative physiology. 2014. PubMed Central
- Solinas M et al. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002. PubMed Central
- Psychology Today. Anxiety and social media use. PsychologyToday.com. 2020. psychologytoday.com
- Shensa A et al. Social Media Use and Depression and Anxiety Symptoms: A Cluster Analysis. American journal of health behavior. 2018. PubMed Central
- Harvard Graduate School of Education. Social media and teen anxiety. Harvard GSE. 2017. gse.harvard.edu
- Vannucci A et al. Social media use and anxiety in emerging adults. Scand J Psychol. 2017. wiley.com
- Onaolapo OJ et al. Monosodium glutamate-associated alterations in open field, anxiety-related and conditioned place preference behaviours in mice. Naunyn Schmiedebergs Arch Pharmacol. 2017. PubMed
- Ureña-Guerrero ME et al. Excitotoxic neonatal damage induced by monosodium glutamate reduces several GABAergic markers in the cerebral cortex and hippocampus in adulthood. Int J Dev Neurosci. 2009. PubMed
- Quines CB et al. Monosodium glutamate, a food additive, induces depressive-like and anxiogenic-like behaviors in young rats. Life Sci. 2014. PubMed
- Porcelli B et al. Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders. Auto Immun Highlights. 2014. PubMed
- Casella G et al. Mood disorders and non-celiac gluten sensitivity. Minerva Gastroenterol Dietol. 2017. PubMed
- Losurdo G et al. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm. World J Gastroenterol. 2018. PubMed
- Addolorato G et al. Anxiety and depression in celiac disease. Intern Emerg Med. 2014. springer.com
- Verywell Health. Gluten-related neurological symptoms. VeryWellHealth.com. verywellhealth.com
- WHO Europe. Alcohol use and mental health. WHO. 2018. euro.who.int
- Norwitz NG et al. Nutrition as Metabolic Treatment for Anxiety. Front Psychiatry. 2021. PubMed
- Bear TLK et al. The Role of the Gut Microbiota in Dietary Interventions for Depression and Anxiety. Adv Nutr. 2020. PubMed
- Firth J et al. Food and mood: how do diet and nutrition affect mental wellbeing?. BMJ. 2020. PubMed
- Adan RAH et al. Nutritional psychiatry: Towards improving mental health by what you eat. Eur Neuropsychopharmacol. 2019. PubMed
- Marx W et al. Nutritional psychiatry: the present state of the evidence. Proc Nutr Soc. 2017. PubMed
- Chao L et al. Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials. Front Neurol. 2020. PubMed
- Sun LJ et al. Gut hormones in microbiota-gut-brain cross-talk. Chin Med J (Engl). 2020. PubMed
- Luna RA et al. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr Opin Biotechnol. 2015. PubMed
- Evrensel A et al. Immune-Kynurenine Pathways and the Gut Microbiota-Brain Axis in Anxiety Disorders. Adv Exp Med Biol. 2020. PubMed
- Martin CR et al. The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018. PubMed
- Schmidt K et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl). 2015. PubMed
- Simpson CA et al. The gut microbiota in anxiety and depression. Front Psychiatry. 2018. frontiersin.org
- Rieder R et al. Microbes and mental health: A review. Brain Behav Immun. 2017. PubMed
- Messaoudi M et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011. PubMed
- Steenbergen L et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015. PubMed
- Taylor AM et al. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. 2020. PubMed
- Dahl WJ et al. Dietary fibre and gut microbiome interactions. Nature Scientific Reports. 2021. nature.com
- New Brain Nutrition. Can prebiotics treat anxiety and depression?. NewBrainNutrition.com. newbrainnutrition.com
- Kao AC et al. The Influence of Prebiotics on Neurobiology and Behavior. Int Rev Neurobiol. 2016. PubMed
- Szklany K et al. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice. Nutr Neurosci. 2020. PubMed
- Diabetes.co.uk. Ketogenic diet and mental health. Diabetes.co.uk. diabetes.co.uk
- Włodarczyk A et al. Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?. Nutrients. 2020. PubMed Central
- Kandola A et al. Exercise and Anxiety. Adv Exp Med Biol. 2020. PubMed
- Streeter CC et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med. 2007. PubMed
- Hayasaka S et al. Effects of charcoal kiln saunas (Jjimjilbang) on psychological states. Complement Ther Clin Pract. 2008. PubMed
- Cain T et al. Effects of cold-water immersion on health and wellbeing: A systematic review and meta-analysis. PLoS One. 2025. PubMed
- Vignes M et al. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res. 2006. PubMed
- Peters CM et al. Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea. Food research international (Ottawa, Ont.). 2010. PubMed Central
- Jerath R et al. Self-regulation of breathing as a primary treatment for anxiety. Appl Psychophysiol Biofeedback. 2015. PubMed
- Psychology Today. Longer exhalations ease anxiety. PsychologyToday.com. 2019. psychologytoday.com
- Feathered Pipe Foundation. How breath affects the nervous system. FeatheredPipe.com. featheredpipe.com
- Kim M et al. Role Identification of Passiflora Incarnata Linnaeus: A Mini Review. Journal of menopausal medicine. 2017. PubMed Central
- Appel K et al. Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2011. sciencedirect.com
- Babaei F et al. Review of the effects of vitexin in oxidative stress-related diseases. Food science & nutrition. 2020. PubMed Central
- Akhondzadeh S et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001. PubMed
- Christoffoli MT et al. Assessment of Passiflora incarnata L for conscious sedation of patients during the extraction of mandibular third molars: a randomized, split-mouth, double-blind, crossover study. Quintessence Int. 2021. PubMed
- Janda K et al. Passiflora incarnata in Neuropsychiatric Disorders-A Systematic Review. Nutrients. 2020. PubMed Central
- Luscher C et al. GABA(A) receptor trafficking-mediated plasticity of inhibitory synapses. Neuron. 2000. nature.com
- Abbasi E et al. Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole-induced seizure in rats. Chem Biol Drug Des. 2012. PubMed
- Grundmann O et al. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med. 2008. PubMed
- Oliveira DR et al. Flavones-bound in benzodiazepine site on GABA(A) receptor: Concomitant anxiolytic-like and cognitive-enhancing effects produced by Isovitexin and 6-C-glycoside-Diosmetin. Eur J Pharmacol. 2018. PubMed
- Šurkienė G et al. Benzodiazepinų vartojimo paplitimas Lietuvoje. Psichiatrija.lt. 2019. psichiatrija.lt
- Lakhan SE et al. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutrition journal. 2010. PubMed Central
- Nojoumi M et al. Effects of Passion Flower Extract, as an Add-On Treatment to Sertraline, on Reaction Time in Patients with Generalized Anxiety Disorder: A Double-Blind Placebo-Controlled Study. Iranian journal of psychiatry. 2016. PubMed Central
- Qi Y et al. Vitexin improves neuron apoptosis and memory impairment induced by isoflurane via regulation of miR-409 expression. Adv Clin Exp Med. 2020. PubMed
- Kim GH et al. Improvement in neurogenesis and memory function by administration of Passiflora incarnata L. extract applied to sleep disorder in rodent models. J Chem Neuroanat. 2019. PubMed
- Sveikatos apsaugos ministerija. Raminamųjų bei migdomųjų vaistų vartojimo grėsmės. SAM.lrv.lt. sam.lrv.lt
- Akhondzadeh S et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther. 2001. PubMed
- Dhawan K. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.–a brief perspective. Addict Biol. 2003. PubMed
- de Oliveira DD et al. Vitexin Possesses Anticonvulsant and Anxiolytic-Like Effects in Murine Animal Models. Frontiers in pharmacology. 2020. PubMed Central
- Nassiri-Asl M et al. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC complementary and alternative medicine. 2007. PubMed Central
- Bourin M et al. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 1997. PubMed
- Singh B et al. Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression. J Ethnopharmacol. 2012. PubMed
- Lai PL et al. Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. Int J Med Mushrooms. 2013. PubMed
- Kolotushkina EV et al. The influence of Hericium erinaceus extract on myelination process in vitro. Fiziol Zh (1994). 2003. PubMed
- Wong KH et al. Neuroregenerative potential of lion’s mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (higher Basidiomycetes), in the treatment of peripheral nerve injury (review). Int J Med Mushrooms. 2012. PubMed
- He X et al. Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s Mane) mushroom: A review. Int J Biol Macromol. 2017. PubMed
- Park YS et al. Effect of an exo-polysaccharide from the culture broth of Hericium erinaceus on enhancement of growth and differentiation of rat adrenal nerve cells. Cytotechnology. 2002. PubMed Central
- Samberkar S et al. Lion’s Mane, Hericium erinaceus and Tiger Milk, Lignosus rhinocerotis (Higher Basidiomycetes) Medicinal Mushrooms Stimulate Neurite Outgrowth in Dissociated Cells of Brain, Spinal Cord, and Retina: An In Vitro Study. Int J Med Mushrooms. 2015. PubMed
- Nagano M et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010. PubMed
- Vigna L et al. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?. Evid Based Complement Alternat Med. 2019. PubMed
- Friedman M. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. J Agric Food Chem. 2015. PubMed
- Chong PS et al. Neurogenesis-dependent antidepressant-like activity of Hericium erinaceus in an animal model of depression. Chin Med. 2021. PubMed
- Brandalise F et al. Dietary Supplementation of Hericium erinaceus Increases Mossy Fiber-CA3 Hippocampal Neurotransmission and Recognition Memory in Wild-Type Mice. Evidence-based complementary and alternative medicine : eCAM. 2017. PubMed Central
- Zhang J et al. The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer’s Disease Mouse Model. International journal of molecular sciences. 2016. PubMed Central
- Mori K et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009. PubMed
- Chong PS et al. Therapeutic Potential of Hericium erinaceus for Depressive Disorder. Int J Mol Sci. 2019. PubMed
- Kim YO et al. Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages. Immunopharmacol Immunotoxicol. 2012. PubMed
- Qin M et al. Anti-Inflammatory Effects of Ethanol Extract of Lion’s Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), in Mice with Ulcerative Colitis. Int J Med Mushrooms. 2016. PubMed
- Mori K et al. Effects of Hericium erinaceus on amyloid β(25-35) peptide-induced learning and memory deficits in mice. Biomed Res. 2011. PubMed
- Velasquez ACA et al. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial. Oral and maxillofacial surgery. 2024. PubMed
- Miyasaka LS et al. Passiflora for anxiety disorder. The Cochrane database of systematic reviews. 2007. PubMed
- Wolfman C et al. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacology, biochemistry, and behavior. 1994. PubMed
- Krenn L [Passion Flower (Passiflora incarnata L.)–a reliable herbal sedative]. Wiener medizinische Wochenschrift (1946). 2002. PubMed
- Medina JH et al. Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochemical pharmacology. 1990. PubMed
- Al Hasan MS et al. Assessment of sedative activity of Chrysin: Behavioral approach with pharmacokinetics, toxicological profile and molecular docking. Sleep medicine. 2025. PubMed
- Nagano M et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical research (Tokyo, Japan). 2010. PubMed
- Vigna L et al. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?. Evidence-based complementary and alternative medicine : eCAM. 2019. PubMed
- Koszła O et al. Biotransformation of Ganoderma lucidum and Hericium erinaceus for ex vivo gut-brain axis modulation and mood-related outcomes in humans: CREB/BDNF signaling and microbiota-driven synergies. Journal of ethnopharmacology. 2025. PubMed
- Mori K et al. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biological & pharmaceutical bulletin. 2008. PubMed
- Lai PL et al. Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. International journal of medicinal mushrooms. 2013. PubMed
- Cipriano GL et al. Beyond Neurotrophins: A Proposed Neurotrophic-Epigenetic Axis Mediated by Non-Coding RNA Networks for Hericium erinaceus Bioactives-A Hypothesis-Driven Review. International journal of molecular sciences. 2026. PubMed
- Roda E et al. Cognitive Healthy Aging in Mice: Boosting Memory by an Ergothioneine-Rich Hericium erinaceus Primordium Extract. Biology. 2023. PubMed
- Ratto D et al. Hericium erinaceus Improves Recognition Memory and Induces Hippocampal and Cerebellar Neurogenesis in Frail Mice during Aging. Nutrients. 2019. PubMed
- Priori EC et al. Hericium erinaceus Extract Exerts Beneficial Effects on Gut-Neuroinflammaging-Cognitive Axis in Elderly Mice. Biology. 2023. PubMed
- Jeanclos E et al. Improved cognition, mild anxiety-like behavior and decreased motor performance in pyridoxal phosphatase-deficient mice. Biochimica et biophysica acta. Molecular basis of disease. 2019. PubMed
- Kasaragod VB et al. Pyridoxal kinase inhibition by artemisinins down-regulates inhibitory neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 2020. PubMed
- Singhuber J et al. GABA(A) receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2012. PubMed
- Evans AK et al. Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. CNS drug reviews. 2007. PubMed
- Zhong H et al. Neonatal inflammation via persistent TGF-β1 downregulation decreases GABA(A)R expression in basolateral amygdala leading to the imbalance of the local excitation-inhibition circuits and anxiety-like phenotype in adult mice. Neurobiology of disease. 2022. PubMed
- Pétursson H The benzodiazepine withdrawal syndrome. Addiction (Abingdon, England). 1994. PubMed
- Soyka M Treatment of Benzodiazepine Dependence. The New England journal of medicine. 2017. PubMed
- O’brien CP Benzodiazepine use, abuse, and dependence. The Journal of clinical psychiatry. 2005. PubMed
- Akhondzadeh S et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. Journal of clinical pharmacy and therapeutics. 2001. PubMed
- Stein MB Neurobiology of generalized anxiety disorder. The Journal of clinical psychiatry. 2009. PubMed
- Pollack MH Refractory generalized anxiety disorder. The Journal of clinical psychiatry. 2009. PubMed
- Richier C et al. Brain Age Prediction in Generalized Anxiety Disorder using a Convolutional Neural Network. Research square. 2025. PubMed
- Amigó J et al. The absence of 5-HT(4) receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT(1A) autoreceptor. Neuropharmacology. 2016. PubMed
- Paliokha R et al. Effects of pre-gestational exposure to the stressors and perinatal mirtazapine administration on the excitability of hippocampal glutamate and brainstem monoaminergic neurons, hippocampal neuroplasticity, and anxiety-like behavior in rats. Molecular psychiatry. 2026. PubMed
- Cryan JF et al. The Microbiota-Gut-Brain Axis. Physiological reviews. 2019. PubMed
- Rutsch A et al. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Frontiers in immunology. 2020. PubMed
- Foster JA et al. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of stress. 2017. PubMed
- Bear T et al. The Microbiome-Gut-Brain Axis and Resilience to Developing Anxiety or Depression under Stress. Microorganisms. 2021. PubMed